Hydromorphone Controlled Release

    Hydromorphone Controlled Release

    [sidebar]

    Funder: Canadian Frailty Network (CFN) and conducted through the SPOR Evidence Alliance; based on prior work funded by the World Health Organization (WHO)

    Click to Download

    Share Buttons [span][/span]

    [ssba-buttons] [/sidebar] [sidebar-content]
    • To examine the rates of IE, HCV infection, and/or HIV infection in adults exposed to controlled release hydromorphone compared to the same infections in adults exposed through prescription or unregulated use of any formulation of immediate release hydromorphone
    • To determine the characteristics of adult HCR users who experienced IE, HCV infection and/or HIV infection, including previous treatment or hospitalization for opioid-related harms
    • N/A at this time
    • N/A at this time

    Related Projects:

    • N/A at this time
    [/sidebar-content]

    Category :

    Date : 20 Jan 2022